Back to News
Market Impact: 0.05
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?
Source: zacks.com
Healthcare & Biotech
The iShares U.S. Pharmaceuticals ETF (IHE), launched on May 1, 2006, is a passively managed fund offering broad exposure to the U.S. pharmaceutical segment of the healthcare equity market. The article provides descriptive fund background and contains no new performance, holdings, flows, or market-moving developments.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- Illumina CEO on Q3 Results and Business Outlook
- UnitedHealth is finally getting its act together. I'm buying into the turnaround
- Swiss Firms Plan Investment Boost in China Drug, Finance Sectors
- Bernstein SocGen raises Eli Lilly stock price target on strong Q3 beat
- Freedom Broker raises Eli Lilly stock price target on GLP-1 demand
- Regeneron Q3 revenue tops estimates on Sanofi Dupixent profit; shares rise 4%